SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-088237
Filing Date
2015-03-12
Accepted
2015-03-12 07:09:29
Documents
3
Period of Report
2015-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d887582d8k.htm 8-K 14924
2 EX-99.1 d887582dex991.htm EX-99.1 73787
3 GRAPHIC g887582ex99_1logo.jpg GRAPHIC 4344
  Complete submission text file 0001193125-15-088237.txt   96283
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 15694394
SIC: 3841 Surgical & Medical Instruments & Apparatus